| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Annovis Bio, Inc. | Director | Common Stock | 6.57K | $40.1K | $6.10 | Nov 20, 2023 | Direct |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Director | Common Stock | 16.5K | $1.45K | $0.09 | Jun 30, 2021 | Direct |
| Annovis Bio, Inc. | Director | Stock Option (right to buy) | 26.2K | Nov 17, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ANVS | Annovis Bio, Inc. | Nov 20, 2023 | 1 | $0 | 4/A | Nov 22, 2023 | Director |
| ANVS | Annovis Bio, Inc. | Nov 17, 2023 | 1 | $0 | 4 | Jul 3, 2024 | Director |
| ANVS | Annovis Bio, Inc. | Apr 7, 2023 | 1 | $6.31K | 4 | Apr 11, 2023 | Director |
| ANVS | Annovis Bio, Inc. | Jan 18, 2023 | 1 | $0 | 4 | Jan 20, 2023 | Director |
| ANVS | Annovis Bio, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| ANVS | Annovis Bio, Inc. | Oct 11, 2021 | 1 | $5.01K | 4 | Oct 13, 2021 | Director |
| ANVS | Annovis Bio, Inc. | Jul 7, 2021 | 1 | $0 | 4 | Jul 9, 2021 | Director |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | Jun 30, 2021 | 1 | $0 | 4 | Jul 7, 2021 | Director |